| 1 | brachytherapy powered by theragenics | | | | | | | 1 | 0.25% |
| 2 | we see newer younger | | | | | | | 1 | 0.25% |
| 3 | many many prostate cancer | | | | | | | 1 | 0.25% |
| 4 | many prostate cancer cases” | | | | | | | 1 | 0.25% |
| 5 | “longterm studies with mature | | | | | | | 1 | 0.25% |
| 6 | studies with mature data | | | | | | | 1 | 0.25% |
| 7 | with mature data substantiate | | | | | | | 1 | 0.25% |
| 8 | mature data substantiate the | | | | | | | 1 | 0.25% |
| 9 | data substantiate the importance | | | | | | | 1 | 0.25% |
| 10 | substantiate the importance of | | | | | | | 1 | 0.25% |
| 11 | brachytherapy especially for highrisk | | | | | | | 1 | 0.25% |
| 12 | especially for highrisk prostate | | | | | | | 1 | 0.25% |
| 13 | for highrisk prostate cancer | | | | | | | 1 | 0.25% |
| 14 | highrisk prostate cancer cases” | | | | | | | 1 | 0.25% |
| 15 | “when we see newer | | | | | | | 1 | 0.25% |
| 16 | see newer younger urologists | | | | | | | 1 | 0.25% |
| 17 | modalities in many many | | | | | | | 1 | 0.25% |
| 18 | newer younger urologists who | | | | | | | 1 | 0.25% |
| 19 | younger urologists who haven’t | | | | | | | 1 | 0.25% |
| 20 | urologists who haven’t been | | | | | | | 1 | 0.25% |
| 21 | who haven’t been exposed | | | | | | | 1 | 0.25% |
| 22 | haven’t been exposed to | | | | | | | 1 | 0.25% |
| 23 | brachytherapy join a group | | | | | | | 1 | 0.25% |
| 24 | join a group with | | | | | | | 1 | 0.25% |
| 25 | a group with an | | | | | | | 1 | 0.25% |
| 26 | group with an experienced | | | | | | | 1 | 0.25% |
| 27 | with an experienced brachytherapy | | | | | | | 1 | 0.25% |
| 28 | an experienced brachytherapy team | | | | | | | 1 | 0.25% |
| 29 | they light up when | | | | | | | 1 | 0.25% |
| 30 | light up when presented | | | | | | | 1 | 0.25% |
| 31 | up when presented with | | | | | | | 1 | 0.25% |
| 32 | in many many prostate | | | | | | | 1 | 0.25% |
| 33 | other modalities in many | | | | | | | 1 | 0.25% |
| 34 | presented with long term | | | | | | | 1 | 0.25% |
| 35 | us to learn more | | | | | | | 1 | 0.25% |
| 36 | the profound impact of | | | | | | | 1 | 0.25% |
| 37 | profound impact of brachytherapy | | | | | | | 1 | 0.25% |
| 38 | impact of brachytherapy on | | | | | | | 1 | 0.25% |
| 39 | of brachytherapy on patient | | | | | | | 1 | 0.25% |
| 40 | brachytherapy on patient outcomes | | | | | | | 1 | 0.25% |